Critics Question Need For AIDS Foundation

WASHINGTON—Resolution of the dispute between American and French researchers over credit for discovery of the AIDS virus and the development of blood tests for the antibody has delighted the science community. But the related decision to create an international AIDS research foundation is being viewed with skepticism by many experts in the field. Under the agreement, announced March 31 by President Ronald Reagan and French Prime Minister Jacques Chirac, the U.S. Department of Health and Hu

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Under the agreement, announced March 31 by President Ronald Reagan and French Prime Minister Jacques Chirac, the U.S. Department of Health and Human Services and France's Pasteur Institute will share the patent for blood test kits and each will donate 80 percent of the royalties to the foundation. Private funds will also be solicited to sponsor grants for AIDS research and education. At least 25 percent of the money will be earmarked for efforts in developing countries.

The market for diagnostic kits in the United States alone is roughly $50 million a year, said Jeffrey Swarz, a drug industry analyst at Goldman, Sachs and Co. "We predict it will reach $200 to $250 million by 1992, and that means a continuous rise in royalties for the foundation," he added. Patent royalties now go to the U.S. Treasury.

The U.S. government estimates that worldwide royalties will total $5 million in 1987, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Amy Mcdonald

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours